Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179022-18-000052)

Filing Details

Accession Number:: 0001179022-18-000052
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-14 16:34:17
Reporting Period:: 2018-06-13

Accepted Time:: 2018-06-14 16:34:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133416	Galectin Therapeutics Inc	GALT	Pharmaceutical Preparations (2834)	043562325

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1266773	W Jack Callicutt	C/O Galectin Therapeutics, Inc. 4960 Peachtree Industrial Blvd., Ste 240 Norcross GA 30071	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-12	9,294	$1.37	10,554	No	4	M	Direct
Common Stock	Disposition	2018-06-12	9,294	$7.01	1,260	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Disposition	2018-06-11	9,294	$0.00	9,294	$1.37

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,706		2026-01-20	No	4	M	Direct

Footnotes

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2018.
The options vested as follows: 25% on January 20, 2016, the grant date, with the remainder vesting ratably on a monthly basis over a three year period.